Breast and Gynecological Cancer Treatments
common.study.values.description
“The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments”
This is a pilot study to test whether PYC can improve climacteric symptoms for women who have experienced either surgically or medically induced menopause as part of their treatment for breast or gynecologic cancers.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Dietary Supplement - 50 mg PYC and then placebo
4 weeks on PYC, then 4 weeks on placebo
Dietary Supplement - 100 mg PYC and then placebo
4 weeks on PYC, then 4 weeks on placebo
Dietary Supplement - Placebo and then 50 mg PYC
4 weeks on placebo, then 4 weeks on PYC
Dietary Supplement - Placebo and then 100 mg PYC
4 weeks on placebo, then 4 weeks of PYC
participant.views.study.view.additional
participant.views.study.view.scientific-title
The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments
common.study.values.clinical-trial-id
NCT03704454
participant.views.study.view.id
dL9Jwe
